Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy

Journal of Allergy and Clinical Immunology

Volumn 130, Issue 1, 2012, Pages

  Swamy, Ravi S ^a   Reshamwala, Neha ^a   Hunter, Tessa ^a   Vissamsetti, Soujanya ^a   Santos, Carah B ^a   Baroody, Fuad M ^b   Hwang, Peter H ^a   Hoyte, Elisabeth G ^a   Garcia, Marco A ^a   Nadeau, Kari C ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

epigenetics; regulatory T cell; Respiratory allergies; sublingual immunotherapy

Indexed keywords

ALLERGEN; CD45RO ANTIGEN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 7 RECEPTOR; PHLEUM PRATENSE ALLERGEN; PLACEBO; PROGRAMMED DEATH 1 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; BASOPHIL; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DNA METHYLATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDEMA; EPIGENETICS; EPIPHORA; FEMALE; GASTROINTESTINAL SYMPTOM; GENE LOCUS; HEADACHE; HOUSE DUST ALLERGY; HUMAN; IMMUNE RESPONSE; LETHARGY; MALE; OAK; PHASE 1 CLINICAL TRIAL; PHLEUM PRATENSE; PHLEUM PRATENSE ALLERGY; PRICK TEST; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; RHINITIS; RHINOCONJUNCTIVITIS; SIDE EFFECT; SNEEZING; SUBLINGUAL IMMUNOTHERAPY; THROAT DISEASE; URTICARIA;

EID: 84862865711     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.04.021     Document Type: Article

References (42)

1. C.A. Akdis, and M. Akdis Mechanisms of allergen-specific immunotherapy J Allergy Clin Immunol 127 2011 18 29
2. G.W. Canonica, J. Bousquet, T. Casale, R.F. Lockey, C.E. Baena-Cagnani, and R. Pawankar Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009 Allergy 64 suppl 91 2009 1 59
3. S.R. Durham, and D.Y. Leung One hundred years of allergen immunotherapy: time to ring the changes J Allergy Clin Immunol 127 2011 3 7
4. M. Jutel, and C.A. Akdis Immunological mechanisms of allergen-specific immunotherapy Allergy 66 2011 725 732
5. H.S. Nelson Subcutaneous immunotherapy J Allergy Clin Immunol 128 2011 907 e3
6. D.R. Wilson, M.T. Lima, and S.R. Durham Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis Allergy 60 2005 4 12
7. S.M. Amar, R.J. Harbeck, M. Sills, L.J. Silveira, H. O'Brien, and H.S. Nelson Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract J Allergy Clin Immunol 124 2009 150 156 e1-5
8. M.A. Calderon, T.B. Casale, A. Togias, J. Bousquet, S.R. Durham, and P. Demoly Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond J Allergy Clin Immunol 127 2011 30 38
9. M. Marogna, M. Bruno, A. Massolo, and P. Falagiani Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: a long-term (13-year) retrospective study in real life Int Arch Allergy Immunol 142 2007 70 78 (Pubitemid 46032987)
10. H.S. Nelson Multiallergen immunotherapy for allergic rhinitis and asthma J Allergy Clin Immunol 123 2009 763 769
11. J.N. Francis, S.J. Till, and S.R. Durham Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy J Allergy Clin Immunol 111 2003 1255 1261 (Pubitemid 36683679)
12. M. Jutel, M. Akdis, F. Budak, C. Aebischer-Casaulta, M. Wrzyszcz, and K. Blaser IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy Eur J Immunol 33 2003 1205 1214 (Pubitemid 36609138)
13. G.W. Scadding, M.H. Shamji, M.R. Jacobson, D.I. Lee, D. Wilson, and M.T. Lima Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells Clin Exp Allergy 40 2010 598 606
14. G. Scadding, and S. Durham Mechanisms of sublingual immunotherapy J Asthma 46 2009 322 334
15. S. Sakaguchi, M. Miyara, C.M. Costantino, and D.A. Hafler FOXP3+ regulatory T cells in the human immune system Nat Rev Immunol 10 2010 490 500
16. M. Miyara, and S. Sakaguchi Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns Immunol Cell Biol 89 2011 346 351
17. G. Wieczorek, A. Asemissen, F. Model, I. Turbachova, S. Floess, and V. Liebenberg Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue Cancer Res 69 2009 599 608
18. H.S. Nelson, H. Nolte, P. Creticos, J. Maloney, J. Wu, and D.I. Bernstein Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults J Allergy Clin Immunol 127 2011 72 80 e1-2
19. F.M. Baroody, S. Ford, D. Proud, A. Kagey-Sobotka, L. Lichtenstein, and R.M. Naclerio Relationship between histamine and physiological changes during the early response to nasal antigen provocation J Appl Physiol 86 1999 659 668 (Pubitemid 29075822)
20. Y. Gernez, R. Tirouvanziam, G. Yu, E.E. Ghosn, N. Reshamwala, and T. Nguyen Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy Int Arch Allergy Immunol 154 2011 318 327
21. K. Nadeau, C. McDonald-Hyman, E.M. Noth, B. Pratt, S.K. Hammond, and J. Balmes Ambient air pollution impairs regulatory T-cell function in asthma J Allergy Clin Immunol 126 2010 845 852 e10
22. F. Acquistapace, F. Agostinis, V. Castella, A. Kantar, E. Novembre, and M.R. Perrone Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial Pediatr Allergy Immunol 20 2009 660 664
23. M. Penagos, E. Compalati, F. Tarantini, R. Baena-Cagnani, J. Huerta, and G. Passalacqua Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials Ann Allergy Asthma Immunol 97 2006 141 148 (Pubitemid 44272577)
24. E.C. TePas, E.G. Hoyte, J.J. McIntire, and D.T. Umetsu Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals Ann Allergy Asthma Immunol 92 2004 25 31 (Pubitemid 38113628)
25. G.W. Scadding, M.H. Shamji, M.R. Jacobson, D.I. Lee, D. Wilson, and M.T. Lima Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells Clin Exp Allergy 40 2010 598 606
26. N. Mothes, M. Heinzkill, K.J. Drachenberg, W.R. Sperr, M.T. Krauth, and Y. Majlesi Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies Clin Exp Allergy 33 2003 1198 1208 (Pubitemid 37108522)
27. K.T. Nouri-Aria, P.A. Wachholz, J.N. Francis, M.R. Jacobson, S.M. Walker, and L.K. Wilcock Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity J Immunol 172 2004 3252 3259 (Pubitemid 38263717)
28. H.J. Buhring, A. Streble, and P. Valent The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis Int Arch Allergy Immunol 133 2004 317 329 (Pubitemid 38490210)
29. J. Kleine-Tebbe, S. Erdmann, E.F. Knol, D.W. MacGlashan Jr., L.K. Poulsen, and B.F. Gibbs Diagnostic tests based on human basophils: potentials, pitfalls and perspectives Int Arch Allergy Immunol 141 2006 79 90
30. Y. Gernez, R. Tirouvanziam, G. Yu, E.E. Ghosn, N. Reshamwala, and T. Nguyen Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy Int Arch Allergy Immunol 154 2011 318 327
31. G. Lal, and J.S. Bromberg Epigenetic mechanisms of regulation of Foxp3 expression Blood 114 2009 3727 3735
32. R. Dahl, A. Kapp, G. Colombo, J.G. de Monchy, S. Rak, and W. Emminger Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis J Allergy Clin Immunol 118 2006 434 440 (Pubitemid 44160721)
33. L.M. Williams, and A.Y. Rudensky Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3 Nat Immunol 8 2007 277 284 (Pubitemid 46745377)
34. J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat Immunol 4 2003 330 336 (Pubitemid 36432314)
35. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057 1061 (Pubitemid 36222930)
36. H.T. Jin, R. Ahmed, and T. Okazaki Role of PD-1 in regulating T-cell immunity Curr Top Microbiol Immunol 350 2011 17 37
37. C. Pilette, K.T. Nouri-Aria, M.R. Jacobson, L.K. Wilcock, B. Detry, and S.M. Walker Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression J Immunol 178 2007 4658 4666 (Pubitemid 46492419)
38. C. Zuany-Amorim, C. Ruffie, S. Haile, B.B. Vargaftig, P. Pereira, and M. Pretolani Requirement for gammadelta T cells in allergic airway inflammation Science 280 1998 1265 1267
39. O. Akbari, P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, and T. Nakayama Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity Nat Med 9 2003 582 588 (Pubitemid 36597105)
40. C. Ebner, U. Siemann, B. Bohle, M. Willheim, U. Wiedermann, and S. Schenk Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen Clin Exp Allergy 27 1997 1007 1015
41. P.A. Wachholz, and S.R. Durham Induction of 'blocking' IgG antibodies during immunotherapy Clin Exp Allergy 33 2003 1171 1174 (Pubitemid 37108518)
42. F.M. Baroody, S. Ford, D. Proud, A. Kagey-Sobotka, L. Lichtenstein, and R.M. Naclerio Relationship between histamine and physiological changes during the early response to nasal antigen provocation J Appl Physiol 86 1999 659 668 (Pubitemid 29075822)